+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Breast Cancer Drugs Market Research Reports

Over a million women worldwide are diagnosed with breast cancer annually. Alongside surgery, radiotherapy and immunotherapy, pharmaceutical products (including hormonal therapy and chemotherapy) are in the frontline against this terrible disease. Market reports in this section enable buyers to read up on the latest breast cancer drug pipelines and R&D strategies, as well as the medical and commercial activities of major players and niche operators such Abraxis Bioscience, Aeterna Zentaris, Agendia BV, Aphton Corp, Array BioPharma, AstraZeneca Plc, Bristol Myers Squibb, Dendreon Corporation, Eli Lilly, Genentech, Genta, Novartis AG, Pfizer, Roche Group, Sanofi-Aventis, Schering AG, Therion Biologics, and ViRexx Medical. Also included are cutting edge academic journals and various expert textbooks for medical professionals involved in breast cancer treatment. Show Less Read more

From
Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight - Product Thumbnail Image

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

  • Clinical Trials
  • October 2016
  • 85 Pages
From
From
From
From
From
From
From
From
From
Glabridin (CAS 59870-68-7) Market Research Report 2017 - Product Thumbnail Image

Glabridin (CAS 59870-68-7) Market Research Report 2017

  • Report
  • February 2017
  • 70 Pages
From
From
From
Tamoxifen (CAS 10540-29-1) Market Research Report 2017 - Product Thumbnail Image

Tamoxifen (CAS 10540-29-1) Market Research Report 2017

  • Report
  • February 2017
  • 70 Pages
From
From
Methotrexate (CAS 59-05-2) Market Research Report 2017 - Product Thumbnail Image

Methotrexate (CAS 59-05-2) Market Research Report 2017

  • Report
  • February 2017
  • 70 Pages
From
From
Loading Indicator
adroll